Most medication errors are preventable with the right conditions. Successful technology implementation requires careful planning, proper training, and a commitment to system-wide improvements, as explained by Stéphane Boulanger, Policy Advisor at the European Patient Safety Foundation (EUPSF).
A new study by the University of Manchester has found that a new clotbusting drug is significantly better at treating ischemic stroke than existing treatments.
An innovative fridge-free vaccine will enter its first-in-human clinical trial at the National Institute for Health and Care Research (NIHR) Southampton Clinical Research Facility.
A landmark study presented at ESCMID Global 2025 reveals the devastating impact of antimicrobial resistance (AMR) on children's health. In 2022, over 3 million children worldwide died from antibiotic-resistant infections, highlighting the urgent need for global action.
New research in the Canadian Medical Association Journal links emergency department opioid prescriptions to small increases in future opioid use and hospitalisations, but not death or overdose. The study highlights the need for cautious prescribing, especially in high-risk patients.
A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient. Researchers identified a RUFY1-RET fusion, highlighting the need for advanced genetic testing to guide treatment strategies and combat evolving resistance.
Sarah Kabbani and Michael Craig from the U.S. Centers for Disease Control and Prevention discuss the organization’s efforts to implement and support antibiotic stewardship.
How can the EU’s pharmaceutical legislation help tackle current challenges, including medicine shortages and antimicrobial resistance, across Europe? We put the question to Rainer Becker, Director for Medical Products and Innovation at DG SANTE.
Aiming to tackle the high risk of heart problems among older Americans with obesity, Medicare is contemplating an expansion of coverage for a weight-loss medication known as semaglutide.
Lorna Rothery spoke to Health Care Without Harm (HCWH) Europe about the impact of pharmaceutical pollution and the barriers that need to be overcome to achieve a greener, more sustainable industry.
Imagine a world where children's medicine tastes like chocolate, seniors can take just one pill for all their daily medications, and you can get a drug made specifically for your unique health needs right at your local pharmacy.
